- 1501. Fluorescence polarization immunoassay (FPIA)
- [Immunoassay, Fluorescence Polarization ( HL7V3.0 )] (UMLS (HL7) C0079365) =Laboratory Procedure ;
=ObservationMethod;
| - 1551. Fluorouracil/Vincristine
- (UMLS (NCI) C0879260) =Therapeutic or Preventive Procedure
|
- 1502. fluorescence recovery after photobleaching
- [method used to study lateral movements of membrane proteins and lipids; a small area of a cell membrane is bleached by laser light and the amount of time necessary for unbleached fluorescent marker tagged proteins to diffuse back into the bleached site is a measurement of the cell membrane's fluidity. ( CSP )] (UMLS (CSP) C1138405) FRAP;
FRAP (fluorescence recovery after photobleaching);
=Laboratory Procedure ;
=fluorimetry;
| - 1552. Fluorouracil/Virulizin
- (UMLS (NCI) C1327757) =Therapeutic or Preventive Procedure; ;
|
- 1503. fluorescence resonance energy transfer
- [method used to evaluate interactions and different conformational states of molecules. ( CSP )] (UMLS (CSP) C0597717) =Laboratory Procedure ;
=fluorescence spectrometry;
| - 1553. Fluosol-DA
- [A perfluorocarbon blood substitute in trials for the treatment of severe anemia ( NCI )] (UMLS (NCI) C0060574) =Organic Chemical; Pharmacologic Substance
|
- 1504. fluorescence spectrometry
- [measurement of the intensity and quality of fluorescence ( CSP )] (UMLS (CSP) C0037802) =Laboratory Procedure ;
=fluorimetry;
=fluorescence resonance energy transfer | - 1554. Fluoxamine
- [A 2-aminoethyl oxime ether of aralkylketones, with antidepressant, antiobsessive-compulsive, and anxiolytic properties. Fluvoxamine, chemically unrelated to other selective serotonin reuptake inhibitors, selectively blocks serotonin reuptake by inhibiting the serotonin reuptake pump at the presynaptic neuronal membrane. This increases serotonin levels within the synaptic cleft, prolongs serotonergic transmission and decreased serotonin turnover, thereby leading to antidepressant, anxiolytic and antiobsessive-compulsive effects. Fluvoxamine shows no significant affinity for histaminergic, alpha or beta adrenergic, muscarinic, or dopaminergic receptors in vitro. ( NCI )] (UMLS (NCI) C0085228) =Organic Chemical; Pharmacologic Substance ;
=[CN600] ANTIDEPRESSANTS;
oxime;
serotonin inhibitor;
[CN302] BENZODIAZEPINE DERIVATIVE, SEDATIVES/HYPNOTICS;
[CN609] ANTIDEPRESSANTS, OTHER;
=FLUVOXAMINE MALEATE |
- 1505. fluorescence spectrophotometry
- [ ] (UMLS (CSP) C0242505) =Laboratory Procedure ;
| - 1555. FLUOXETINE
- [N-methyl-gamma-(4-(trifluoromethyl) -phenoxy)-benzenepropanamine; used in the treatment of depression; action thought to be linked to its inhibition of CNS neuronal uptake of serotonin. ( CSP )] (UMLS (NCI) C0016365) =Organic Chemical; Pharmacologic Substance ;
=[CN600] ANTIDEPRESSANTS;
Propylamines;
serotonin inhibitor;
phenylalkoxyalkylamine;
[CN609] ANTIDEPRESSANTS, OTHER;
=FLUOXETINE HYDROCHLORIDE;
FLUOXETINE 10 MG;
FLUOXETINE 40 MG;
|
- 1506. fluorescence spectroscopy
- [Fluorescent spectroscopy or fluorometry is a type of electromagnetic spectroscopy used for analyzing fluorescent spectra. It involves using a beam of light, usually ultraviolet light, that excites the electrons in molecules of certain compounds and causes them to emit light of a lower energy, typically, but not necessarily, visible light. ( NCI )] (UMLS (CSP) C0242506) =Laboratory Procedure ;
| - 1556. Fluoxymesterone/Tamoxifen
- (UMLS (NCI) C0280900) =Therapeutic or Preventive Procedure
|
- 1507. fluorescent antibody
- [any immunohistochemical method using antibody labeled with a fluorescent dye and frequently examined by fluorescence microscopy. ( CSP )] (UMLS (CSP) C0016318) =Laboratory Procedure =immunocytochemistry;
| - 1557. Fluphenazine Enanthate
- (UMLS (NCI) C0066682) =Organic Chemical; Pharmacologic Substance =1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI);
=FLUPHENAZINE ENANTHATE 25 MG/ML |
- 1508. fluorescent dye
- [dyes that emit light when exposed to light; the wave length of the emitted light is usually longer than that of the incident light; fluorochromes are substances that cause fluorescence in other substances, that is, dyes used to mark or label other compounds with fluorescent tags, and they are used as markers in biochemistry and immunology. ( CSP )] (UMLS (CSP) C0016320) =Indicator, Reagent, or Diagnostic Aid =dye;
=ethidium;
FLUORESCEIN;
radiofluorescent probe;
| - 1558. Fluprazine
- (UMLS (NCI) C0117988) =Organic Chemical; Pharmacologic Substance ;
|
- 1509. fluorescent probe
- [ ] (UMLS (CSP) C0016321) =Indicator, Reagent, or Diagnostic Aid
| - 1559. FLUPREDNISOLONE
- [A synthetic glucocorticoid with anti-inflammatory properties. ( MSH )] (UMLS (NCI) C0016369) =Steroid; Pharmacologic Substance; Hormone
|
- 1510. Fluoresone
- (UMLS (NCI) C0619286) =Organic Chemical
| - 1560. Fluprowit
- (UMLS (NCI) C1449419) Muco Sanigen;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance |
- 1511. fluoridation
- [incorporation or addition of fluoride in a compound. ( CSP )] (UMLS (CSP) C0687703) =Natural Phenomenon or Process ;
=halogenation;
| - 1561. FLURAZEPAM
- [benzodiazepine derivative used mainly as a sedative and hypnotic in the treatment of insomnia. ( CSP )] (UMLS (NCI) C0016375) =Organic Chemical; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
benzodiazepine;
Benzodiazepinones;
[CN300] SEDATIVES/HYPNOTICS;
Muscle Relaxant;
[CN302] BENZODIAZEPINE DERIVATIVE, SEDATIVES/HYPNOTICS =FLURAZEPAM HYDROCHLORIDE;
|
- 1512. fluorimetry
- [the measurement of fluorescence. ( CSP )] (UMLS (CSP) C0016352) =Laboratory Procedure =spectrometry;
=fluorescence spectrometry;
fluorescence recovery after photobleaching | - 1562. Flurithromycin
- (UMLS (NCI) C0060591) =Organic Chemical; Antibiotic
|
- 1513. fluoro fatty acid
- [ ] (UMLS (CSP) C0598430) =Lipid ;
| - 1563. Flurizan
- (UMLS (NCI) C1327755) =Organic Chemical; Pharmacologic Substance
|
- 1514. fluoroaminoacid
- [amino acid containing fluoride. ( CSP )] (UMLS (CSP) C0596580) =Amino Acid, Peptide, or Protein ;
=haloaminoacid;
=2-(Difluoromethyl)-DL-ornithine | - 1564. fluroxene
- [ ] (UMLS (CSP) C0016381) =Organic Chemical; Pharmacologic Substance ;
|
- 1515. fluorocarbon polymer
- [dense, inert resin made up of carbon and fluorine, with or without other halogens or hydrogen. ( CSP )] (UMLS (CSP) C0016337) =Organic Chemical =fluorohydrocarbon;
plastic | - 1565. Flush
- [Flush ( HL7V3.0 )] (UMLS (HL7) C1696091) =Functional Concept =RouteByMethod;
=Flush, intravenous catheter;
|
- 1516. fluorocarbon respiratory assist
- [ ] (UMLS (CSP) C0599337) =Therapeutic or Preventive Procedure ;
| - 1566. Flush, intravenous catheter
- [Flush, intravenous catheter ( HL7V3.0 )] (UMLS (HL7) C1553213) =Functional Concept =IntravenousRoute;
Flush |
- 1517. Fluorocarbons
- [Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions and fluorocarbon blood substitutes. ( MSH )] (UMLS (HL7) C0016340) =Organic Chemical =artificial blood;
fluorohydrocarbon =perfluorodecalin;
Perflubron | - 1567. FLUSHING
- [A sudden reddening of the face. ( NCI )] (UMLS (ICD9CM) C0016382) =Sign or Symptom =Clinical Finding;
|
- 1518. Fluorochrome
- [A class of dyes when excited by light of certain wavelengths, emit photons and become fluorescent. Fluorescence gives fluorochromes imaging characteristics and are used to label or stain biological structures. ( NCI )] (UMLS (NCI) C0016342) =Indicator, Reagent, or Diagnostic Aid
| - 1568. FLUT/KCZ
- (UMLS (NCI) C0281151) =Therapeutic or Preventive Procedure ;
|
- 1519. fluorodeoxyglucose
- [ ] (UMLS (CSP) C0872172) =Carbohydrate; Pharmacologic Substance
| - 1569. FLUT/KCZ/LEUP
- (UMLS (NCI) C0281150) =Therapeutic or Preventive Procedure ;
|
- 1520. fluorodiazepam
- [ ] (UMLS (CSP) C0598453) =Organic Chemical
| - 1570. FLUT/LEUP
- (UMLS (NCI) C0280778) =Therapeutic or Preventive Procedure
|
- 1521. Fluorodopan
- [An alkylating agent with potential antineoplastic activity. Fluorodopan alkylates DNA at the N7 position of guanine. Alkylating agents exert cytotoxic and, in some cases, chemotherapeutic effects by transferring alkyl groups to DNA, thereby damaging DNA and interfering with DNA replication and cell division. (NCI04) ( NCI )] (UMLS (NCI) C0060560) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 1571. FLUT/LEUP/somatuline/SUR
- (UMLS (NCI) C0281028) =Therapeutic or Preventive Procedure
|
- 1522. fluorohydrocarbon
- [organic compound that contains carbon and hydrogen, with fluorine atoms substituting for one or more hydrogens. ( CSP )] (UMLS (CSP) C0020249) =Organic Chemical =Halogenated Hydrocarbon;
=fluorocarbon polymer;
fluosol;
Fluorocarbons;
Chlorofluorocarbons;
| - 1572. FLUT/LEUP/SUR
- (UMLS (NCI) C0280880) =Therapeutic or Preventive Procedure
|
- 1523. FLUOROMETHOLONE
- [A synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Fluorometholone exerts its effects by interacting with cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. ( NCI )] (UMLS (NCI) C0016351) =Steroid; Pharmacologic Substance ;
=Pregnadienediols;
Steroids, Fluorinated;
[OP300] ANTI-INFLAMMATORIES, TOPICAL OPHTHALMIC;
=9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 17-acetate;
FLUOROMETHOLONE 0.1 % | - 1573. FLUT/SUR/ZDX
- (UMLS (NCI) C0281616) =Therapeutic or Preventive Procedure
|
- 1524. fluorophore
- [ ] (UMLS (CSP) C0598447) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid ;
| - 1574. FLUT/TRIP
- (UMLS (NCI) C0796488) Flutamide/Triptorelin;
=Therapeutic or Preventive Procedure ;
|
- 1525. Fluorophotometry
- [Measurement of light given off by fluorescein in order to assess the integrity of various ocular barriers. The method is used to investigate the blood-aqueous barrier, blood-retinal barrier, aqueous flow measurements, corneal endothelial permeability, and tear flow dynamics (From MSH2001). ( NCI )] (UMLS (NCI) C0016353) =Diagnostic Procedure
| - 1575. FLUT/ZDX
- (UMLS (NCI) C0278891) =Therapeutic or Preventive Procedure
|
- 1526. Fluoroplex
- (UMLS (NCI) C0699375) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 1576. Flutamide/Toremifene
- (UMLS (NCI) C0935888) =Therapeutic or Preventive Procedure
|
- 1527. fluoropyrimidine
- [group of compounds which seem to have antineoplastic activity. ( CSP )] (UMLS (CSP) C0596581) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =pyrimidine analog;
=1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil;
2,4-Dioxo-5-fluoropyrimidine;
5 fluorouridine | - 1577. Flutazolam
- (UMLS (NCI) C0060593) =Organic Chemical ;
|
- 1528. fluoroscope
- [(FLOOR-o-skope) An x-ray machine that makes it possible to see internal organs in motion. ( NCI )] (UMLS (NCI) C0180921) =Medical Device
| - 1578. FLUTICASONE
- [A synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Fluticasone binds and activates glucocorticoid receptor, resulting in the activation of lipocortin. Lipocortin, in turn, inhibits cytosolic phospholipase A2, which triggers a cascade of reactions involved in the synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production. ( NCI )] (UMLS (NCI) C0082607) =Organic Chemical; Pharmacologic Substance ;
=Androstadienes;
[NT200] ANTI-INFLAMMATORIES, NASAL;
[RE101] ANTI-INFLAMMATORIES, INHALATION;
=(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, S-(Fluoromethyl) Ester;
FLUTICASONE 100 MCG;
FLUTICASONE 250 MCG;
FLUTICASONE 500 MCG |
- 1529. fluoroscopic image intensifier
- [An image-intensified fluoroscopic X-ray system is a device intended to visualize anatomical structures by converting a pattern of X-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories. ( SPN )] (UMLS (CSP) C0492215) =Medical Device
| - 1579. Flutonidine
- (UMLS (NCI) C0060595) =Organic Chemical; Pharmacologic Substance
|
- 1530. fluoroscopy
- [production of an image when x-rays strike a fluorescent screen. ( CSP )] (UMLS (NCI) C0016356) =Diagnostic Procedure =Endoscopic;
radiography | - 1580. Flutoprazepam
- (UMLS (NCI) C0117998) =Organic Chemical; Pharmacologic Substance
|
- 1531. Fluorotestosterone
- [A synthetic nonaromatizable androgen analog of testosterone. Fluorotestosterone (6 alpha-fluorotestosterone) binds to and activates specific nuclear receptors inhibits and is equipotent to testosterone. (NCI04) ( NCI )] (UMLS (NCI) C0049381) =Steroid; Pharmacologic Substance
| - 1581. Flutter, ventricular
- [A ventricular tachyarrhythmia characterized electrocardiographically by smooth undulating waves with QRS complexes merged with T waves, a rate of approximately 250 per minute. ( NCI )] (UMLS (NCI) C0152173) =Pathologic Function
|
- 1532. Fluorouracil-Uracil/Gemcitabine/Leucovorin Calcium
- (UMLS (NCI) C0796674) =Therapeutic or Preventive Procedure
| - 1582. FLUVASTATIN
- [A synthetic lipid-lowering agent with antilipidemic and potential antineoplastic properties. Fluvastatin competitively inhibits hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses through the suppression of MHC II (major histocompatibility complex II) on interferon gamma-stimulated antigen-presenting cells such as human vascular endothelial cells. Due to its anti-inflammatory effects mediated by alterations of lipid metabolism, fluvastatin may possess chemopreventive and therapeutic antineoplastic properties. ( NCI )] (UMLS (NCI) C0082608) =Organic Chemical; Pharmacologic Substance ;
=[CV350] ANTILIPEMIC AGENTS;
Fatty Acids, Monounsaturated;
Indole;
=(3R,5S,6E)-(+/-)-7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic Acid;
|
- 1533. Fluorouracil/Gefitinib/Irinotecan/Leucovorin Calcium
- (UMLS (NCI) C1134514) =Therapeutic or Preventive Procedure
| - 1583. flying
- [to move in or pass through the air with wings; this is for the act of movement through air by wings; for transportation by airplane use AVIATION. ( CSP )] (UMLS (CSP) C0677530) =Phenomenon or Process ;
=body movement;
|
- 1534. Fluorouracil/Gefitinib/Leucovorin Calcium/Oxaliplatin
- (UMLS (NCI) C1134492) =Therapeutic or Preventive Procedure
| - 1584. Flying Phobia
- (UMLS (NCI) C0344318) =Mental or Behavioral Dysfunction ;
|
- 1535. Fluorouracil/Gemcitabine/Oxaliplatin
- (UMLS (NCI) C0879418) =Therapeutic or Preventive Procedure
| - 1585. flying squirrel
- [ ] (UMLS (CSP) C1265492) =Mammal
|
- 1536. Fluorouracil/Gemcitabine/Paclitaxel
- (UMLS (NCI) C0879345) =Therapeutic or Preventive Procedure
| - 1586. FM HX ENDO/METAB DIS NEC
- [ ] (UMLS (ICD9CM) C1955577) Other endocrine and metabolic diseases;
=Disease or Syndrome |
- 1537. Fluorouracil/IM-862
- (UMLS (NCI) C0879574) =Therapeutic or Preventive Procedure
| - 1587. FMdC
- [A synthetic purine nucleoside analog with potential antineoplastic activity. Phosphorylated by cellular kinases, tezacitabine is converted into its active diphosphate and triphosphate metabolites. The diphosphate form binds to and irreversibly inhibits activity of ribonucleotide reductase (RNR), an enzyme overexpressed in many tumor types and is responsible for the conversion of ribonucleoside diphosphates to deoxyribonucleotides necessary for DNA synthesis. A shortage of deoxyribonuleotides inhibits DNA replication and induces apoptosis. The triphosphate form acts as a substrate for DNA polymerase, thereby further compromises DNA replication. In addition, tezacitabine is relatively resistant to metabolic deactivation by cytidine deaminase. ( NCI )] (UMLS (NCI) C0253087) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 1538. Fluorouracil/Irinotecan
- (UMLS (NCI) C0935708) =Therapeutic or Preventive Procedure
| - 1588. fMLP (formyl-met-leu-phe)
- [N-Formylmethionyl-leucyl-phenylalanine. A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated. ( MSH )] (UMLS (CSP) C0027229) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 1539. Fluorouracil/Irinotecan/Leucovorin Calcium/Monoclonal Antibody ABX-EGF
- (UMLS (NCI) C1327789) =Therapeutic or Preventive Procedure ;
| - 1589. FMLP Receptor
- [Expressed in neutrophils by human FPR1 Gene (GPCR1 Family), 350-aa 38-kDa Formyl Peptide Receptor 1 is a high affinity integral membrane protein GPCR (activates a PI-calcium second messenger system) for N-Formyl-Methionyl peptides, which are powerful chemotactic and activation factors for neutrophils. ( NCI )] (UMLS (NCI) C0118022) =Amino Acid, Peptide, or Protein; Receptor
|
- 1540. Fluorouracil/irinotecan/leucovorin calcium/oxaliplatin
- (UMLS (NCI) C0879464) =Therapeutic or Preventive Procedure ;
| - 1590. FMN reductase
- [An enzyme that utilizes NADH or NADPH to reduce FLAVINS. It is involved in a number of biological processes that require reduced flavin for their functions such as bacterial bioluminescence. Formerly listed as EC 1.6.8.1 ( MSH )] (UMLS (CSP) C0068341) =Amino Acid, Peptide, or Protein; Enzyme ;
=iron sulfur protein;
NAD(P)H oxidoreductase;
respiratory enzyme;
|
- 1541. Fluorouracil/Irinotecan/Leucovorin Calcium/SU5416
- (UMLS (NCI) C0935893) =Therapeutic or Preventive Procedure
| - 1591. FMRFamide
- [A molluscan neuroactive peptide which induces a fast excitatory depolarizing response due to direct activation of amiloride-sensitive SODIUM CHANNELS. (From Nature 1995; 378(6558): 730-3) ( MSH )] (UMLS (CSP) C0060608) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine
|
- 1542. Fluorouracil/Leucovorin Calcium/Lonafarnib
- (UMLS (NCI) C0796671) =Therapeutic or Preventive Procedure
| - 1592. fMRI
- [A noninvasive tool used to observe functioning in the brain or other organs by detecting changes in chemical composition, blood flow, or both. ( NCI )] (UMLS (NCI) C0376335) =Diagnostic Procedure =magnetic resonance imaging;
brain imaging/visualization/scanning |
- 1543. Fluorouracil/Leucovorin Calcium/Oblimersen/Oxaliplatin
- (UMLS (NCI) C1327901) =Therapeutic or Preventive Procedure ;
| - 1593. FNCLCC Sarcoma Grade 1
- (UMLS (NCI) C1335913) Sarcoma Differentiation Score 1;
Sarcoma FNCLCC Grade 1;
=Neoplastic Process |
- 1544. Fluorouracil/Leucovorin Calcium/Oxaliplatin/PTK787
- (UMLS (NCI) C1328037) Fluorouracil/Leucovorin Calcium/Oxaliplatin/PTK787(ZK 222584) =Therapeutic or Preventive Procedure; ;
| - 1594. FNCLCC Sarcoma Grade 2
- (UMLS (NCI) C1335914) Sarcoma Differentiation Score 2;
Sarcoma FNCLCC Grade 2;
=Neoplastic Process |
- 1545. Fluorouracil/Leucovorin Calcium/Oxaliplatin/Trastuzumab
- (UMLS (NCI) C0879557) =Therapeutic or Preventive Procedure
| - 1595. FNCLCC Sarcoma Grade 3
- (UMLS (NCI) C1335915) Sarcoma Differentiation Score 3;
Sarcoma FNCLCC Grade 3;
=Neoplastic Process |
- 1546. Fluorouracil/Leucovorin Calcium/Oxaliplatin/ZD6126
- (UMLS (NCI) C1328166) =Therapeutic or Preventive Procedure; ;
| - 1596. FNCLCC Tumor Grade in Sarcoma
- (UMLS (NCI) C1335920) Sarcoma by FNCLCC Grade;
Sarcoma by FNCLCC Tumor Differentiation Score;
Tumor Differentiation Score in Sarcoma =Neoplastic Process |
- 1547. Fluorouracil/Leucovorin Calcium/SU5416
- (UMLS (NCI) C0796685) =Therapeutic or Preventive Procedure
| - 1597. foam cell
- [Lipid-laden macrophages originating from monocytes or from smooth muscle cells. (MeSH) ( NCI )] (UMLS (CSP) C0016390) =Cell
|
- 1548. Fluorouracil/Leucovorin Calcium/Triacetyluridine
- (UMLS (NCI) C0879400) =Therapeutic or Preventive Procedure
| - 1598. foaming agent
- [ ] (UMLS (CSP) C0599512) =Chemical Viewed Functionally ;
|
- 1549. Fluorouracil/Leucovorin Calcium/UCN-01
- (UMLS (NCI) C1327740) =Therapeutic or Preventive Procedure ;
| - 1599. foaming retardant
- [ ] (UMLS (CSP) C0016391) =Chemical Viewed Functionally
|
- 1550. Fluorouracil/UCN-01
- (UMLS (NCI) C0879295) =Therapeutic or Preventive Procedure
| - 1600. Foamy Retrovirus
- [Various species of spumavirus. ( NCI )] (UMLS (NCI) C0080153) =Virus
|
home 
Armenian-English 
top